It beat convincingly on both the top and bottom lines. For its first quarter of this year, AbbVie's net revenue was $13.3 billion, representing a sturdy 8% improvement on a year-over-year basis.

AbbVie (ABBV) delivered impressive financial results for the first quarter of 2025. Investors responded enthusiastically, pushing AbbVie’s stock up 3.15% on the announcement day and 8.70% for ...